In a groundbreaking move, Health Canada has approved Wegovy (semaglutide injection) as the first medication of its kind to reduce the risk of non-fatal heart attacks in adults with obesity or overweight. People living with obesity are more than twice as likely to have heart disease than those with a healthy weight.
This decision signals hope for millions of Canadians struggling with the interconnected challenges of weight and cardiovascular health.
A Dual Approach: Weight and Heart Health
Wegovy, already known for its role in weight management, has now been recognized for its heart-protective benefits. Recent clinical trials revealed that this once-weekly injection reduced the likelihood of non-fatal heart attacks or strokes by 20%. These findings are particularly significant for individuals who not only face challenges with weight but are also at a higher risk of cardiovascular events.
Conditions such as type 2 diabetes, hypertension, and heart disease are often linked to excess weight, making it a complex health challenge. By addressing both weight and cardiovascular risks, Wegovy offers a comprehensive approach to improving health outcomes.
Why This Matters
Heart disease remains the 2nd leading cause of death in Canada, with thousands of individuals experiencing life-altering heart attacks each year. For many, these events are preventable through better management of risk factors such as weight, blood pressure, and cholesterol.
Yet, achieving and maintaining a healthy weight is far from easy. It’s a challenge influenced by genetics, lifestyle, socioeconomic factors, and even emotional health. Wegovy represents a new option for Canadians who have struggled with traditional weight-loss methods like diet and exercise alone.
A Step Forward, Not a Standalone Solution
Wegovy is intended for individuals with obesity or overweight who have additional health risks, and it works best when paired with a doctor-approved plan that includes diet, exercise, and lifestyle changes.
By reducing excess weight, individuals may also experience improvements in other health markers, such as blood sugar levels and overall fitness, further enhancing their quality of life.
Access and Affordability
With this approval, the conversation now shifts to ensuring access and affordability for those who can benefit most from Wegovy. Many Canadians face financial barriers when it comes to medications, and the inclusion of such treatments in insurance plans or provincial healthcare programs could play a critical role in its reach.
Moving the Needle on Preventive Care
The approval of Wegovy by Health Canada highlights the importance of innovative treatments in tackling the dual crises of obesity and cardiovascular health. It’s a reminder that addressing one health issue can often lead to broader benefits, making prevention and early intervention key priorities in healthcare.
“Canadians living with obesity are at increased risk of heart attacks. We welcome expanded treatment options to support Canadians living with obesity and related complications. People deserve evidence-based care to proactively manage this disease, including medical nutrition therapy, psychological interventions, physical activity, pharmacotherapy and surgery,” said Dr. Sanjeev Sockalingam, Scientific Director of Obesity Canada.
For Canadians seeking to improve their heart health while managing their weight, this new option provides an opportunity to discuss individualized plans with their healthcare providers. As Wegovy becomes available, it has the potential to change lives and reduce the burden of cardiovascular disease across the country.
~Read more from The Health Insider~
- Weight-Loss Med Wegovy Now Approved to Treat Heart Attack Risk
Discover how the medication Wegovy tackles obesity and reduces heart attack risk by 20% – a breakthrough for many Canadians. - Ozempic and GLP-1 Drugs – Surprising New Health Benefits
From diabetes care to potential benefits for heart health, Alzheimer’s, and more, GLP-1 drugs like Ozempic are reshaping medicine. - Canada’s Legendary Cardiologists
Learn about Canada’s ground-breaking cardiologists and the work that transformed cardiology medicine, research and education.
The information provided on TheHealthInsider.ca is for educational purposes only and does not substitute for professional medical advice. TheHealthInsider.ca advises consulting a medical professional or healthcare provider when seeking medical advice, diagnoses, or treatment.